A central online news resource for professionals involved in the development of medical publications and involved in publication planning and medical writing.
Data sharing must become routine argue Richard Smith and Ian Roberts in a recent opinion article published on F1000Research. They acknowledge that researchers are incentivised to publish papers rather than … Continue Reading Why do researchers refuse to share their data?
As a prerequisite for publication of research, the International Committee of Medical Journal Editors (ICMJE) requires registration of clinical trials and recommends this to editors of medical journals. Similarly, provision … Continue Reading Retrospective vs. prospective registration of clinical trials – what is the norm?
In a recent blog Dr Ben Goldacre, from Oxford University DataLab, describes the concept of OpenTrials, an open platform for locating and sharing all freely available data and documents from … Continue Reading OpenTrials: all clinical trial data in one place
Author: Jo Chapman, PhD (Aspire Scientific Ltd) Over two days last week, around 250 delegates and exhibitors braved sub-zero temperatures to attend the European meeting of the International Society for … Continue Reading Meeting report: Summary of Day 2 of the 2016 European ISMPP Meeting
Author: Jo Chapman, PhD (Aspire Scientific Ltd) Over two days last week, around 250 delegates and exhibitors braved sub-zero temperatures to attend the European meeting of the International Society for … Continue Reading Meeting report: Summary of Day 1 of the 2016 European ISMPP Meeting
The 2016 European meeting of the International Society for Medical Publication Professionals (ISMPP) has just finished. Hopefully, the tweet stream below will be helpful in providing highlights of what was presented at … Continue Reading Want to know what the highlights were from the 2016 ISMPP European Meeting? See the #ISMPP tweet stream here
An educational meeting was held at Alderley Park in Cheshire on the afternoon of the 3rd of December, entitled: “Improving efficiency, transparency and integrity in medical publications: overview of the … Continue Reading Improving efficiency, transparency and integrity in medical publications: overview of the latest guidelines
A new study published in BMJ Open found that for 15 drugs approved by the US Food and Drug Administration (FDA) in 2012, a median 57% of clinical trials were … Continue Reading Clinical trial registration, reporting, publication and FDAAA compliance
In 2005, the International Committee of Medical Journal Editors (ICMJE) introduced mandatory trial registration guidelines and member journals require prospective registration of trials prior to patient enrolment as a condition … Continue Reading Evidence that industry may be better than academia at prospective trial registration, though improvements are required
A study published in PLOS ONE in the past week investigated if the number of null results in large National Heart Lung, and Blood Institute (NHLBI) funded trials has increased … Continue Reading Likelihood of “negative” publications from large NHLBI clinical trials has increased over time
In an unprecedented move, a group of 85 asset managers and pension funds is teaming with a U.K. non-profit campaign (AllTrials campaign) to pressure pharmaceutical companies to disclose clinical trial data (i.e. get … Continue Reading Pharma company investors call for clinical trials transparency
In a recent article in the Journal of Clinical Epidemiology, Ben Goldacre discusses the importance and need for improving the availability/publication of clinical trial data – particularly from the perspective … Continue Reading Fixing flaws in science must be professionalised
An Editorial has been published this week in The BMJ to mark the 10th anniversary of the landmark decision by the International Committee of Medical Journal Editors (ICMJE) to make … Continue Reading Trial registration: the single most valuable tool we have to ensure unbiased reporting of research studies
A study published in June in Current Medical Research and Opinion assessed the timely disclosure of results of company-sponsored clinical trials related to all new medicines approved by the European … Continue Reading Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials
The 4th World Conference on Research Integrity recently took place in Rio de Janeiro (from 31 May-3 June). The main theme for the conference was “How to improve the research … Continue Reading Presentations now available from the 4th World Conference on Research Integrity
A study published in PLOS ONE last week attempted to characterise the reasons why trials (listed on http://www.clinicaltrials.gov) were terminated, and also examined the availability of results from these trials. … Continue Reading Terminated trials in the ClinicalTrials.gov results database: reasons for termination and availability of results